Skip to main content
. 2023 May 26;12(6):766. doi: 10.3390/pathogens12060766

Table 1.

Studies on FMT clinical benefits in IBD patients.

Kunde, S. et al. (2013) [45]
  • Included 10 pediatric patients with active UC

  • FMT with enemas for 5 days

  • Clinical remission at 1 week after FMT

Zhang, F. M. et al. (2013) [48]
  • Study case of CD complicated with fistula

  • Treated with FMT as a rescue therapy

Gianluca Ianiro et al. (2014) [49]
  • A total of 42 patients received FMT nasogastric or nasojejunal tube and gastroscopy

  • A total of 20 patients received FMT enemas

  • A total of 23 through colonoscopy

  • A total of 11 patients had FMT via gastroscopy and colonoscopy

  • FMT obtained a reduction in symptoms of 71%

Mańkowska-Wierzbicka, D. et al. (2020) [46]
  • Included 10 patients with active UC

  • Multisession FMT by colonoscopy/gastroscopy

  • FMT improves calprotectin levels and Truelove and Witts scores

  • 16S rRNA gene sequencing was used for metagenomic analysis showing changes and enrichment in the gut microbiota with healthy microbes

Quagliariello, A. et al. (2020) [25]
  • Pilot study of two pediatric patients with refractory disease

  • FMT showed no adverse effects, and endoscopic appearance was improved

Crothers, J. et al. (2021) [47]
  • Included 12 patients with active UC

  • Ribosomal 16S bacterial sequencing revealed changes in the microbiota

  • FMT induced clinical remission compared to placebo